ABVX

Abivax SA - ADR

111.21

USD

ABVX Earnings Reports

Positive Surprise Ratio

ABVX beat 2 of 5 last estimates.

40%

Next Report

Date of Next Report

Mar 23, 2026

Estimate for Q4 25 (Revenue/ EPS)

$2.04M

-$1.52

Implied change from Q3 25 (Revenue/ EPS)

Implied change from Q4 24 (Revenue/ EPS)

-63.79%

+1.33%

Abivax SA - ADR earnings per share and revenue

On Dec 15, 2025, ABVX reported earnings of -- USD per share (EPS) for Q3 25, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.

Looking ahead to Q4 25, 4 analysts forecast an EPS of -1.52 USD, with revenue projected to reach 2.04 million USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Regeneron Pharmaceuticals Inc

Report Date

Jan 30, 2026 For Q4 25

Estimate

$10.84

Actual

$11.44

Surprise

+5.52%

Nurix Therapeutics, Inc. Common stock

Report Date

Jan 28, 2026 For Q4 25

Estimate

-$0.88

Actual

-$0.82

Surprise

+7.66%

FAQ

What were Abivax SA - ADR's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Abivax SA - ADR reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.

How did the market react to Abivax SA - ADR's Q3 2025 earnings?

The stock price moved -- --, changed from -- before the earnings release to -- the day after.

When is Abivax SA - ADR expected to report next?

The next earning report is scheduled for Mar 23, 2026.

What are the forecasts for Abivax SA - ADR's next earnings report?

Based on 4 analysts, Abivax SA - ADR is expected to report EPS of -$1.52 and revenue of $2.04M for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.